Opinions are luxury items, so I try not to have more than I can afford. An opinion, of course, is different from a belief, ...

If you can relate to any of my story, here's what you should be asking yourself to examine the cause of yours.

The medical technology stock is in a consolidation pattern and testing a key level. The biotech had a beat-and-raise quarter.

ICMR reports that 56% of chronic diseases in India are linked to unhealthy diets and poor lifestyle choices The Indian ...

Life expectancy is one of the clearest mirrors of a community’s health, and in one Southern state that reflection is ...

Nausea, a major hurdle for millions using weight-loss drugs like Ozempic, may soon be a thing of the past. Researchers are ...

Mutton, chicken, and fish offer distinct nutritional benefits beyond protein. Fish provides light, omega-3 rich nourishment ...

In April 2025, Kevin Hall took early retirement from the US National Institutes of Health (NIH). “My life's work has been to ...

Discover why Phathom's stock is rated 'Buy' after strong Q3 results, rising revenue guidance, and remarkable vonoprazan sales ...

Millions of electricity customers in President Donald Trump's adopted home state of Florida will see their bills rise, after a regulatory board approved what environmental advocates say is one of the ...

Two physician-led practices are making strong progress after recently launching their membership-based, preventive-care ...

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that the U.S. Food and Drug Administration (FDA) has accepted Sangamo’s request for a rolling submission and ...